Effect of Resistance Training on Musculoskeletal Endocrine Interactions
NCT ID: NCT02040727
Last Updated: 2015-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2013-10-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In light of well-established accolades of resistance training, historical recommendations for avoidance among the pediatric population have deterred implementation of resistance training interventions in young adolescents. However, contemporary data indicating a profound benefit of resistance training to the skeletal system in pre-adolescents has led to the Academy of Sports Medicine, as well as various other pediatric health interest groups, to support supervised programs incorporating resistance training in young children, emphasizing large muscle and core strengthening. To date, such trials have not been conducted in the pediatric population
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome
NCT00727779
Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)
NCT02561377
Effect of Exercise on Metabolic Health
NCT02001142
Effects of Home-based Resistance Exercise on Body Composition, Muscle Strength and Glycemic Control in People With Type 2 Diabetes.
NCT04136730
Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss
NCT01452074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Communication across systems is reliant upon various hormones which interact on the regulation of glucose homeostasis, bone metabolism, and muscle development. While it is well-established that bone and muscle growth are dependent upon fuel utilization, factors secreted by bone and muscle have been recently shown to play an interactive role in glucose homeostasis. Data derived primarily from animal models have demonstrated maintenance of physiological levels promote optimal growth and development, whereas these hormones appear to have adverse effects when levels are altered. While the data in animals is compelling, translation in humans has not been conducted.
Speculatively, impaired glucose homeostasis, much attributable to decreased strain on the musculoskeletal system, promotes impairments in physiological roles of these hormones. As a result, disordered development may be of consequence, such that the bones grow bigger yet have impaired quality, and delivery of fuel to muscle is compromised. Obesity-induced perturbations in metabolism and tissue partitioning may be an added stress to the system, impairing muscle function, power, performance and overall quality. Strategies that optimize the protective effects of the musculoskeletal system may be encompassed by forced stress on the system via resistance training, known to influence synthesis and release of hormones involved in fuel delivery and utilization by muscle and bone. The strategy proposed will target optimization of musculoskeletal health, promoting synthesis and release of musculoskeletal-derived signals providing protection on metabolic health at a critical period of development.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Resistance Trained
No Participation in Resistance Training
No Resistance Training
No supervised strength training throughout the study
Resistance Trained
Participation in Resistance Training
Resistance Training
Supervised strength training 3 days per week for 24 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance Training
Supervised strength training 3 days per week for 24 weeks
No Resistance Training
No supervised strength training throughout the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* early pubertal boys (Tanner stage \<3)
* ages 7-12 years
* self-identified as Non-Hispanic Black.
Exclusion Criteria
* musculoskeletal disorders
* disturbances in glucose or lipid metabolism
* use of thyroid medication, diuretics, beta-blockers, or any medication that potentially could affect body composition, the lipid profile, insulin sensitivity, or blood pressure
* allergy to EMLA cream
* history of eating disorders, cancer, kidney disease, endocrinopathy, liver disease, heart disease, or thyroid disease
* medically determined not to be able to engage in resistance training
7 Years
12 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lynae J. Hanks, PhD. RD
Post-Doctoral Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orlando M Gutierrez, MD, MMSc
Role: STUDY_DIRECTOR
University of Alabama at Birmingham
Lynae J Hanks, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Krista Casazza, PhD, RD
Role: STUDY_DIRECTOR
University of Alabama at Birmingham
Marcas Bamman, PhD
Role: STUDY_DIRECTOR
University of Alabama at Birmingham
Ambika Ashraf, MD
Role: STUDY_CHAIR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hanks LJ, Gutierrez OM, Ashraf AP, Casazza K. Bone Mineral Content as a Driver of Energy Expenditure in Prepubertal and Early Pubertal Boys. J Pediatr. 2015 Jun;166(6):1397-403. doi: 10.1016/j.jpeds.2015.02.054. Epub 2015 Apr 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.